Cero Therapeutics Holdings Stock Performance

CERo Therapeutics Relative Risk vs. Return Landscape

If you would invest  8.90  in CERo Therapeutics Holdings on November 14, 2025 and sell it today you would lose (4.40) from holding CERo Therapeutics Holdings or give up 49.44% of portfolio value over 90 days. CERo Therapeutics Holdings is currently does not generate positive expected returns and assumes 9.7883% risk (volatility on return distribution) over the 90 days horizon. In different words, 87% of stocks are less volatile than CERo, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.Given the investment horizon of 90 days CERo Therapeutics is expected to under-perform the market. In addition to that, the company is 12.68 times more volatile than its market benchmark. It trades about -0.07 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.14 per unit of volatility.

CERo Therapeutics Target Price Odds to finish over Current Price

Given the investment horizon of 90 days the stock has the beta coefficient of 1.41 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, CERo Therapeutics will likely underperform. Additionally CERo Therapeutics Holdings has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.

Predictive Modules for CERo Therapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as CERo Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Hype Prediction Low Estimated High 0.00 0.04 9.89 Details

Intrinsic Valuation Low Real High 0.38 7.53 17.38 Details

2 Analysts Consensus Low Target High 27.30 30.00 33.30 Details

Earnings Estimates (0) Low Projected EPS High -1 -1 -1 Details

CERo Therapeutics Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. CERo Therapeutics is not an exception. The market had few large corrections towards the CERo Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold CERo Therapeutics Holdings, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of CERo Therapeutics within the framework of very fundamental risk indicators.

CERo Therapeutics Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of CERo Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for CERo Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.

CERo Therapeutics Price Density Drivers

CERo Therapeutics Fundamentals Growth

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CERo Therapeutics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Understanding CERo Therapeutics requires distinguishing between market price and book value, where the latter reflects CERo's accounting equity. The concept of intrinsic value - what CERo Therapeutics' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push CERo Therapeutics' price substantially above or below its fundamental value.

It's important to distinguish between CERo Therapeutics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding CERo Therapeutics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, CERo Therapeutics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.